المصدر: Zacks Investment Research
وكالة أنباء
الأسهم
أهمية متوسطة
JAZZ Q2 Earnings Miss, Sales Beat, Stock Jumps on Raised '26 View
Jazz Pharmaceuticals tops Q2 sales estimates and raises its 2026 revenue outlook despite an EPS miss, as strong oncology and neuroscience demand lifts shares.
الرموز ذات الصلة
1
J
JAZZ
JAZZ
المصدر: Zacks Investment Research
زيارة المصدر